Last reviewed · How we verify
picolax drops
Picolax drops is an osmotic laxative containing sodium picosulfate that stimulates bowel motility and increases stool water content to promote defecation.
Picolax drops is an osmotic laxative containing sodium picosulfate that stimulates bowel motility and increases stool water content to promote defecation. Used for Constipation, Bowel preparation prior to colonoscopy or other gastrointestinal procedures.
At a glance
| Generic name | picolax drops |
|---|---|
| Sponsor | Ahmed M Maged, MD |
| Drug class | Osmotic laxative |
| Target | Colonic smooth muscle and osmotic effect |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
Sodium picosulfate is a prodrug that is converted by colonic bacteria into bis-(p-hydroxyphenyl)-pyridyl-methane, which acts as an osmotic agent and stimulates colonic contractions. This increases intraluminal fluid volume and accelerates intestinal transit, resulting in bowel evacuation. The drops formulation allows for flexible dosing and is commonly used for bowel preparation and constipation relief.
Approved indications
- Constipation
- Bowel preparation prior to colonoscopy or other gastrointestinal procedures
Common side effects
- Abdominal cramping
- Nausea
- Diarrhea
- Electrolyte imbalance
Key clinical trials
- Lubiprostone for Functional Constipation in the Under 18 Years Patients (PHASE3)
- The Efficacy of Chewing Gums Versus Laxative in Early Return of Bowel Function After CS (PHASE4)
- Pharmacokinetics of Bisacodyl or Sodium Picosulfate Administered Orally in Healthy Lactating Females (PHASE1)
- Sodium Picosulphate vs. Placebo in Functional Constipation (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- picolax drops CI brief — competitive landscape report
- picolax drops updates RSS · CI watch RSS
- Ahmed M Maged, MD portfolio CI